BBMC Cardiovascular Disorders10d agoComparative effectiveness and safety of inclisiran versus evolocumab and alirocumab: a 180-day real-world studyJiafang Yao·WenJuan Wang·Qiyin Sun·Dan Liu·Junling LinRead at BMC Cardiovascular DisordersTagsPsoriasis: Treatment and PathogenesisImmunology
